BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kyowa Hakko Kirin 

Ohtemachi Building 5F
1-6-1 Ohtemachi, Chiyoda-ku
Tokyo    100-8185  Japan
Phone: 81-3-3282-0007 Fax: 81-3-3284-1968


SEARCH JOBS




Industry
Biotechnology






 Company News
ArQule, Inc. (ARQL) Announces Commencement Of Phase 3 Clinical Trial With Tivantinib In Hepatocellular Carcinoma By Partner Kyowa Hakko Kirin In Japan 2/4/2014 9:46:24 AM    More...
The NovAliX/Kyowa Hakko Kirin Alliance Will Commence A Fragment-Based Drug Discovery Project Targeting An Important Protein/Protein Interaction 11/18/2013 10:49:47 AM    More...
Ultragenyx Pharmaceuticals Announces the Presentation of Data From a Single Dose Phase 1 Study, Conducted by Kyowa Hakko Kirin, of KRN23 in X-linked Hypophosphatemia (XLH) in Adults 10/7/2013 9:45:31 AM    More...
Abstral® , Manufactured and Packaged by Recipharm AB for Kyowa Hakko Kirin, Has Been Approved in Japan 9/23/2013 8:22:40 AM    More...
Activiomics Extends Research Agreement With Kyowa Hakko Kirin as Part of Its Strategic Partnership With BioFocus DPI 9/19/2013 9:40:30 AM    More...
Ultragenyx Pharmaceuticals Announces Collaboration With Kyowa Hakko Kirin to Develop and Commercialize Phase 2-Stage KRN23 for X-Linked Hypophosphatemia 9/4/2013 12:46:21 AM    More...
La Jolla Institute for Allergy and Immunology Continues Longtime Collaboration With Kyowa Hakko Kirin 8/1/2013 10:35:22 AM    More...
Ezose Sciences, Inc. Enters Glycomics Research Agreement With Kyowa Hakko Kirin 1/28/2013 2:14:47 PM    More...
NovAliX Enters Into Fragment-Based Drug Discovery Alliance With Kyowa Hakko Kirin 1/14/2013 11:00:24 AM    More...
Adimab LLC. Announces New Discovery Collaboration ith Kyowa Hakko Kirin 1/7/2013 10:23:38 AM    More...
123